We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+2.3%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$741M
AUM Growth
+$38.7M
Cap. Flow
+$31.5M
Cap. Flow %
4.25%
Top 10 Hldgs %
60.64%
Holding
104
New
35
Increased
22
Reduced
3
Closed
10

Top Buys

Rank Stock Value
1
WAB icon
Wabtec
WAB
+$12.3M
2
WAT icon
Waters Corp
WAT
+$9M
3
DO
Diamond Offshore Drilling
DO
+$6.09M
4
GILD icon
Gilead Sciences
GILD
+$5.17M
5
RTX icon
RTX Corp
RTX
+$4.82M

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$27.9M
2
CSCO icon
Cisco
CSCO
+$2.32M
3
LGND icon
Ligand Pharmaceuticals
LGND
+$1.06M
4
UTHR icon
United Therapeutics
UTHR
+$1.05M
5
DBVT
DBV Technologies
DBVT
+$1.03M

Sector Composition

Rank Sector Weight
1 Financials 38.94%
2 Healthcare 24.52%
3 Industrials 11.96%
4 Technology 10.74%
5 Energy 5.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRK.A icon
1
Berkshire Hathaway Class A
BRK.A
$1.11T
$178M 24.01%
699
– –
WFC icon
2
Wells Fargo
WFC
$264B
$85.6M 11.54%
1,544,420
– –
IBM icon
3
IBM
IBM
$225B
$46.2M 6.23%
314,009
-185,351
-37% -$27.9M
MMM icon
4
3M
MMM
$94.4B
$23.2M 3.13%
133,234
– –
JNJ icon
5
Johnson & Johnson
JNJ
$626B
$22.7M 3.07%
171,900
– –
PX
6
DELISTED
Praxair Inc
PX
$20M 2.7%
151,020
– –
RTX icon
7
RTX Corp
RTX
$302B
$18.8M 2.53%
244,229
+64,354
+36% +$4.82M
DVA icon
8
DaVita
DVA
$11.4B
$18.7M 2.52%
288,900
– –
DHR icon
9
Danaher
DHR
$146B
$18.2M 2.46%
243,422
+6,091
+3% +$456K
NVO
10
Novo Nordisk
NVO
$207B
$18.2M 2.45%
847,600
– –
PSX icon
11
Phillips 66
PSX
$89.5B
$17.8M 2.41%
215,700
+11,400
+6% +$895K
AGN
12
DELISTED
Allergan plc
AGN
$17.4M 2.34%
71,400
– –
ROP icon
13
Roper Technologies
ROP
$39.5B
$16.3M 2.2%
70,600
– –
V icon
14
Visa
V
$677B
$16.1M 2.17%
171,900
– –
WAB icon
15
Wabtec
WAB
$50.3B
$15.7M 2.11%
171,200
+147,500
+622% +$12.3M
BA icon
16
Boeing
BA
$184B
$15M 2.02%
75,900
– –
POT
17
DELISTED
Potash Corp Of Saskatchewan
POT
$13.6M 1.84%
836,200
+107,700
+15% +$1.78M
SRCL
18
DELISTED
Stericycle Inc
SRCL
$9.92M 1.34%
130,000
– –
NOV icon
19
NOV
NOV
$7.49B
$9.66M 1.3%
293,400
+28,100
+11% +$970K
WAT icon
20
Waters Corp
WAT
$40.7B
$9.52M 1.28%
+51,800
New +$9M
GILD icon
21
Gilead Sciences
GILD
$168B
$9.15M 1.23%
129,330
+77,630
+150% +$5.17M
FTV icon
22
Fortive
FTV
$18.6B
$8.98M 1.21%
224,703
+57,881
+35% +$2.28M
SNY icon
23
Sanofi
SNY
$104B
$8.21M 1.11%
171,300
– –
CELG
24
DELISTED
Celgene Corp
CELG
$7.46M 1.01%
57,400
– –
AMGN icon
25
Amgen
AMGN
$224B
$7.35M 0.99%
42,700
+1,200
+3% +$195K
1
2 3 4 5

Similar funds

QIM
Quest Investment Management Lake Oswego, Oregon $857M AUM 21.67% 1-Year Est. Return
NOCM
Night Owl Capital Management Greenwich, Connecticut $858M AUM 31.41% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
EPIMS
Evelyn Partners Investment Management Services London $850M AUM 20.89% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Hikari Power's Q2 2017 Portfolio in Review

As of Q2 2017, Hikari Power held 104 positions worth $741M, up 5.5% from $703M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Hikari Power deployed $31.5M of net new capital in Q2 2017, opening 35 new positions and adding to 22 existing holdings. Its largest new stake was Waters Corp: 51,800 shares worth $9.52M.

By sector, the portfolio is most concentrated in Financials at 39% of assets, down from 40% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was IBM, an estimated $27.9M trimmed.

  • Hikari Power's largest Q2 2017 buy was Waters Corp: 51,800 shares worth $9.52M.
  • Hikari Power added most to Wabtec in Q2 2017, an estimated $12.3M increase.
  • Hikari Power's biggest Q2 2017 reduction was IBM, cutting an estimated $27.9M.
  • Hikari Power fully exited Ligand Pharmaceuticals in Q2 2017, selling an estimated $1.06M.
  • Hikari Power's ten largest holdings make up 61% of its $741M portfolio in Q2 2017.
  • Hikari Power opened 35 new positions and closed 10 in Q2 2017.
  • Hikari Power's portfolio value rose 5.5% quarter-over-quarter to $741M.

Based on Hikari Power's 13F filing for Q2 2017, filed 9 Aug 2017.